Topic List : Genetics
Pilot grants for population health projects
The Stanford Center for Population Health Sciences has awarded 11 pilot grants to investigators with studies that seek to improve population and community health.
Too many unnecessary double mastectomies?
Women with breast cancer do not receive timely genetic testing or have adequate access to effective genetic counseling, which may compromise treatment decisions, according to research from Stanford and the University of Michigan.
Possible therapeutic approach for ALS
A set of experiments at Stanford reveals that suppressing a protein called ataxin 2 dramatically extends survival and improves motor function in a mouse model of ALS.
Master cell regulator blocks all but one outcome
A regulatory protein actively blocks the expression of non-neuronal genes in nerve cells, according to new Stanford research. The finding suggests there are many master regulators to help cell types maintain their identities.
Fat accumulation can lengthen life
Roundworms storing monounsaturated fats in their guts live longer, according to Stanford researchers. Their study links epigenetic regulation with fat metabolism, and may have implications for many species.
Many breast cancer patients ‘undertested’
Physicians often fail to recommend genetic testing to breast cancer patients at high risk for cancer-associated mutations. Improving access to genetic counseling about the testing process and results is a key priority.
$10.5M in grants for encyclopedia of DNA
Stanford’s William Greenleaf, Michael Bassik, Michael Snyder, Jonathan Pritchard and Michael Cherry have won grants to work on the federally funded Encyclopedia of DNA Elements.
1 cent ‘lab on a chip’
Microfluidics, electronics and inkjet technology underlie a newly developed all-in-one biochip from Stanford that can analyze cells for research and clinical applications.
Researchers get $26.4 million for activity study
The medical school professors were awarded the grants as part of a large-scale National Institutes of Health program to study the biology of how physical activity improves health.
Child’s life saved by experimental drug
Four-year-old Zoe Harting is doing well after participating in a phase-2 clinical trial of the first drug for a deadly genetic disease, spinal muscular atrophy type 1.